New York, NY (PRWEB) August 11, 2013
Bernstein Liebhard LLP is investigating Januvia lawsuits (http://www.januvialawsuithelp.com/) on behalf of Type 2 diabetics who took Januvia and were later diagnosed with pancreatic cancer, pancreatitis or thyroid cancer. According to court documents, a growing number of Januvia lawsuits have been filed against Merck & Co. that accuse the drug maker of failing to warn doctors and patients of an association between the use of Januvia and pancreatic cancer, as well as pancreatitis. The U.S. Judicial Panel on Multidistrict Litigation (JPML) is expected to make a decision soon regarding the establishment of a multidistrict litigation for all federal lawsuits involving allegations that Januvia and similar diabetes medications can increase risks for pancreatic cancer, pancreatitis and thyroid cancer. (In Re: Incretins Products Liability, Sales and Marketing Litigation, MDL 2452, JPML)
“We have heard from a number of Januvia users who have been diagnosed with pancreatic cancer, pancreatitis and thyroid cancer. The body of evidence pointing to a possible connection between the use of drugs like Januvia and an increased risk for these diseases continues to grow,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Januvia lawsuit consultations to anyone who may have been harmed after taking Januvia or a similar drug.
Januvia and Pancreatic Cancer
Januvia belongs to a class of type 2 diabetes drugs known as incretin mimetics, which help regulate blood sugar by stimulating insulin production by the pancreas. In 2009, a caution regarding a potential Januvia pancreatitis risk was added to the drug’s label after the U.S. Food & Drug Administration (FDA) became aware of 88 post-marketing cases of acute pancreatitis in patients taking Januvia.* In 2011, a study published in Gastroenterology found that use of Januvia appeared to increase the risk of pancreatitis and pancreatic cancer, while two cases of thyroid cancer were also reported in the patients who took Januvia.**
The FDA announced in March that it was investigating incretin mimetics after results from an unpublished study indicated these medications might cause pre-cancerous changes in the pancreas. While the agency has not yet been able to confirm a conclusive link between the use of such drugs and pancreatic cancer, it has said its “review is ongoing as pancreatitis and pancreatic cancer data are being collected.”*** Most recently, a report published June 10th in the British Medical Journal revealed previously unpublished data that indicated the manufacturers of incretin mimetics may have downplayed the drugs’ potential to harm the pancreas.****
Patients who have developed pancreatic cancer, thyroid cancer or pancreatitis that may be related to the use of Januvia could be entitled to compensation for medical bills, lost wages, pain and suffering and more. Learn More about the possible link between Januvia and pancreatic cancer by visiting Bernstein Liebhard LLP’s website. For more information, please call 800-511-5092.
**http://www.gastrojournal.org/article/S0016-5085%2811%2900172-7/abstract, Gastroenterology, February 21, 2011
***pharmalive.com/fda-decides-no-risk-of-pancreatic-cancer-with-diabetes-drugs, Pharmalot, July 31, 2013
****bmj.com/open-data/incretin#alternate; BMJ, June 10, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com